10-Q Filing

COMMUNITY HEALTH SYSTEMS INC CIK: 1108109 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001193125-16-757128`
Period End Date	20160930
Filing Date	20161102
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	cyh-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 129 Cash Flow Statement 86 Comprehensive Income 31

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful patient accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$3.75B	USD	Point-in-time
Allowance for doubtful patient accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.11B	USD	Point-in-time
Other current assets of hospitals held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$17.00M	USD	Point-in-time
Other current assets of hospitals held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$11.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$133.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Noncurrent assets of hospitals held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$109.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$186.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Noncurrent assets of hospitals held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$41.00M	USD	Point-in-time
Patient accounts receivable, net of allowance for doubtful accounts of $3,754 and $4,110 at September 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNetCurrent`	$3.61B	USD	Point-in-time
Patient accounts receivable, net of allowance for doubtful accounts of $3,754 and $4,110 at September 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNetCurrent`	$3.18B	USD	Point-in-time
Current liabilities of hospitals held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.00M	USD	Point-in-time
Current liabilities of hospitals held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$13.00M	USD	Point-in-time
Supplies	`Supplies`	$580.00M	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Supplies	`Supplies`	$527.00M	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$33.00M	USD	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$27.00M	USD	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$208.00M	USD	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$197.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets (including assets of hospitals held for sale of $11 and $17 at September 30, 2016 and December 31, 2015, respectively)	`OtherAssetsCurrent`	$461.00M	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets (including assets of hospitals held for sale of $11 and $17 at September 30, 2016 and December 31, 2015, respectively)	`OtherAssetsCurrent`	$567.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.54B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	113.63M	shares	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$14.91B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	113.73M	shares	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$13.38B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.79B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.55B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	113.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	112.76M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.11B	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	975,549.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.83B	USD	Point-in-time
Goodwill	`Goodwill`	$8.96B	USD	Point-in-time
Goodwill	`Goodwill`	$6.90B	USD	Point-in-time
Other assets, net (including assets of hospitals held for sale of $109 and $41 at September 30, 2016 and December 31, 2015, respectively)	`OtherAssetsNoncurrent`	$2.35B	USD	Point-in-time
Other assets, net (including assets of hospitals held for sale of $109 and $41 at September 30, 2016 and December 31, 2015, respectively)	`OtherAssetsNoncurrent`	$1.96B	USD	Point-in-time
Total assets	`Assets`	$26.59B	USD	Point-in-time
Total assets	`Assets`	$22.23B	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$229.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$240.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.02B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26B	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$227.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$151.00M	USD	Point-in-time
Accrued liabilities (including liabilities of hospitals held for sale of $13 and $6 at September 30, 2016 and December 31, 2015, respectively)	`AccruedLiabilitiesCurrent`	$1.28B	USD	Point-in-time
Accrued liabilities (including liabilities of hospitals held for sale of $13 and $6 at September 30, 2016 and December 31, 2015, respectively)	`AccruedLiabilitiesCurrent`	$1.36B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.07B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.69B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$15.08B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$16.56B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$593.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$357.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.62B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.70B	USD	Point-in-time
Total liabilities	`Liabilities`	$19.75B	USD	Point-in-time
Total liabilities	`Liabilities`	$21.92B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$553.00M	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$571.00M	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 113,633,148 shares issued and outstanding at September 30, 2016, and 113,732,933 shares issued and 112,757,384 shares outstanding at December 31, 2015	`CommonStockValue`	$1.00M	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 113,633,148 shares issued and outstanding at September 30, 2016, and 113,732,933 shares issued and 112,757,384 shares outstanding at December 31, 2015	`CommonStockValue`	$1.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.96B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.97B	USD	Point-in-time
Treasury stock, at cost, no shares at September 30, 2016 and 975,549 shares at December 31, 2015	`TreasuryStockValue`	$7.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-63.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-73.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-64.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-93.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-90.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-87.00M	USD	Point-in-time
(Accumulated deficit) retained earnings	`RetainedEarningsAccumulatedDeficit`	$-60.00M	USD	Point-in-time
(Accumulated deficit) retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.13B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' equity	`StockholdersEquity`	$1.82B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' equity	`StockholdersEquity`	$4.02B	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$106.00M	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$86.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.11B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.93B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$22.23B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$26.59B	USD	Point-in-time

Income Statement 129 line items

Line Item	Tag	Value	Unit	Period
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$5.08B	USD	1 Quarter
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$16.13B	USD	3 Qtrs
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$16.84B	USD	3 Qtrs
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$5.58B	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$2.20B	USD	3 Qtrs
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$734.00M	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$2.16B	USD	3 Qtrs
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$704.00M	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$14.64B	USD	3 Qtrs
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.38B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.85B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$13.97B	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$6.71B	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$2.24B	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$2.07B	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$6.54B	USD	3 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$762.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$2.27B	USD	3 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$2.28B	USD	3 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$723.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$3.37B	USD	3 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$3.26B	USD	3 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$1.03B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$1.14B	USD	1 Quarter
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$10.00M	USD	3 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	3 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$10.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$5.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$54.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$54.00M	USD	3 Qtrs
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$135.00M	USD	3 Qtrs
Rent	`LeaseAndRentalExpense`	$109.00M	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$340.00M	USD	3 Qtrs
Rent	`LeaseAndRentalExpense`	$344.00M	USD	3 Qtrs
Rent	`LeaseAndRentalExpense`	$115.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$839.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$265.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$875.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$288.00M	USD	1 Quarter
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$39.00M	USD	1 Quarter
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$6.00M	USD	3 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$1.70B	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$4.23B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$4.50B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$13.45B	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$14.90B	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$351.00M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$1.19B	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$146.00M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-935.00M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-242.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-233.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-730.00M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-723.00M	USD	3 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	3 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-16.00M	USD	3 Qtrs
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$38.00M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$51.00M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$12.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$4.00M	USD	1 Quarter
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.56B	USD	3 Qtrs
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$502.00M	USD	3 Qtrs
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$121.00M	USD	1 Quarter
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-83.00M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$38.00M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$167.00M	USD	3 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-141.00M	USD	3 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-29.00M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-1.42B	USD	3 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-54.00M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$83.00M	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$335.00M	USD	3 Qtrs
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-2.00M	USD	1 Quarter
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-22.00M	USD	3 Qtrs
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-5.00M	USD	1 Quarter
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-4.00M	USD	3 Qtrs
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$1.00M	USD	3 Qtrs
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$2.00M	USD	3 Qtrs
Loss on sale, net	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-3.00M	USD	1 Quarter
Loss on sale, net	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-3.00M	USD	3 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-2.00M	USD	1 Quarter
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-5.00M	USD	3 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-8.00M	USD	1 Quarter
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-27.00M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$75.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-56.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.43B	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$308.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$67.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$73.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-79.00M	USD	1 Quarter
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-1.50B	USD	3 Qtrs
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$52.00M	USD	1 Quarter
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$241.00M	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-13.50	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.52	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.33	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.69	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.05	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.24	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.07	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.02	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$0.45	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$-0.71	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$-13.55	USD	3 Qtrs
Net (loss) income	`EarningsPerShareBasic`	$2.09	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-13.50	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.51	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.69	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.32	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.24	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.02	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.05	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.07	USD	1 Quarter
Net (loss) income	`EarningsPerShareDiluted`	$2.08	USD	3 Qtrs
Net (loss) income	`EarningsPerShareDiluted`	$-0.71	USD	1 Quarter
Net (loss) income	`EarningsPerShareDiluted`	$0.44	USD	1 Quarter
Net (loss) income	`EarningsPerShareDiluted`	$-13.55	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	110.89M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	114.98M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	115.32M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	110.67M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	110.67M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	110.89M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.85M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	116.37M	shares	1 Quarter

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$75.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-56.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.43B	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$308.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$839.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$876.00M	USD	3 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$10.00M	USD	3 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	3 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvision`	$10.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$36.00M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$10.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$15.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$44.00M	USD	3 Qtrs
Loss on sale, net	`GainLossOnDispositionOfAssets1`	$-4.00M	USD	3 Qtrs
Impairment of hospitals sold or held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOfOrSold`	$1.00M	USD	3 Qtrs
Impairment of hospitals sold or held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOfOrSold`	$8.00M	USD	3 Qtrs
Impairment of goodwill and long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$1.70B	USD	3 Qtrs
Impairment of goodwill and long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$70.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	3 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-16.00M	USD	3 Qtrs
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	3 Qtrs
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-22.00M	USD	3 Qtrs
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-19.00M	USD	3 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$291.00M	USD	3 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$40.00M	USD	3 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$72.00M	USD	3 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$-64.00M	USD	3 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-256.00M	USD	3 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-239.00M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$67.00M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$62.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$615.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$810.00M	USD	3 Qtrs
Acquisitions of facilities and other related equipment	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$41.00M	USD	3 Qtrs
Acquisitions of facilities and other related equipment	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$122.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$696.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$561.00M	USD	3 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$12.00M	USD	3 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$87.00M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$10.00M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$13.00M	USD	3 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$127.00M	USD	3 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$395.00M	USD	3 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$123.00M	USD	3 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$386.00M	USD	3 Qtrs
Proceeds from sale of investments in unconsolidated affiliates	`ProceedsFromSaleOfEquityMethodInvestments`	$403.00M	USD	3 Qtrs
Distribution from Quorum Health Corporation	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$1.22B	USD	3 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$136.00M	USD	3 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$201.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-777.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$751.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$24.00M	USD	3 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00M	USD	3 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$20.00M	USD	3 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$22.00M	USD	3 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$30.00M	USD	3 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$19.00M	USD	3 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$18.00M	USD	3 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$69.00M	USD	3 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$69.00M	USD	3 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$3.46B	USD	3 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$3.93B	USD	3 Qtrs
Proceeds from receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$112.00M	USD	3 Qtrs
Proceeds from receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$66.00M	USD	3 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$5.49B	USD	3 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$3.62B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.61B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-161.00M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-323.00M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-51.00M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$133.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$186.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$133.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$186.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Interest payments	`InterestPaidNet`	$293.00M	USD	1 Quarter
Interest payments	`InterestPaidNet`	$767.00M	USD	3 Qtrs
Interest payments	`InterestPaidNet`	$752.00M	USD	3 Qtrs
Interest payments	`InterestPaidNet`	$279.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$1.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$10.00M	USD	3 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$6.00M	USD	3 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$2.00M	USD	1 Quarter

Comprehensive Income 31 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$75.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-56.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.43B	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$308.00M	USD	3 Qtrs
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-21.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$10.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-11.00M	USD	3 Qtrs
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-22.00M	USD	3 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-10.00M	USD	3 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-8.00M	USD	3 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-7.00M	USD	1 Quarter
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-9.00M	USD	1 Quarter
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	3 Qtrs
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-3.00M	USD	3 Qtrs
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-16.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-29.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-30.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$3.00M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$278.00M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-53.00M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.44B	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$46.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$73.00M	USD	3 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$67.00M	USD	3 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-76.00M	USD	1 Quarter
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-1.52B	USD	3 Qtrs
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$211.00M	USD	3 Qtrs
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$23.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.